Finance

Lists
540596:BOM
Eris Lifesciences Ltd
₹1 162,60
+1,37%
(+15,70) 1D
8 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 540596...
Open
₹1 148,05
High
₹1 184,40
Low
₹1 144,10
Mkt. cap
161,87 mjd
Avg. vol.
10,60 k
Volume
18,24 k
Dividend
0,62%
Quarterly dividend
₹1,80
Ex-dividend date
13 Feb. 2025
P/E ratio
24,87
52-wk high
₹1 737,00
52-wk low
₹1 142,15
EPS
₹46,75
Shares outstanding
137,52 m
No. of employees
3 k
Open
₹1 148,05
High
₹1 184,40
Low
₹1 144,10
Mkt. cap
161,87 mjd
Avg. vol.
10,60 k
Volume
18,24 k
Dividend
0,62%
Quarterly dividend
₹1,80
Ex-dividend date
13 Feb. 2025
P/E ratio
24,87
52-wk high
₹1 737,00
52-wk low
₹1 142,15
EPS
₹46,75
Shares outstanding
137,52 m
No. of employees
3 k
News stories
From web sources and news partners
About Eris Lifesciences Ltd
CEO-
Employees2,76 k
Founded2007
Headquarters-
SectorPharmaceutical industry
Websiteeris.co.in
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
7,90 mjd
8,01 mjd
7,52 mjd
8,69 mjd
Cost of goods sold
2,02 mjd
2,23 mjd
2,10 mjd
2,39 mjd
Cost of revenue
2,02 mjd
2,23 mjd
2,10 mjd
2,39 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,37 mjd
1,38 mjd
1,52 mjd
1,53 mjd
Operating expense
3,69 mjd
3,66 mjd
3,38 mjd
4,06 mjd
Total operating expenses
5,71 mjd
5,90 mjd
5,48 mjd
6,45 mjd
Operating income
2,19 mjd
2,11 mjd
2,04 mjd
2,24 mjd
Other non operating income
28,10 m
200,00 k
-19,40 m
23,90 m
EBT including unusual items
1,73 mjd
1,45 mjd
1,59 mjd
1,79 mjd
EBT excluding unusual items
1,73 mjd
1,63 mjd
1,59 mjd
1,79 mjd
Income tax expense
382,00 m
365,20 m
-1,20 mjd
361,70 m
Effective tax rate
22,12%
25,13%
-75,08%
20,15%
Other operating expenses
1,62 mjd
1,58 mjd
1,16 mjd
1,80 mjd
Net income
1,20 mjd
997,20 m
2,82 mjd
1,42 mjd
Net profit margin
15,21%
12,45%
37,44%
16,38%
Earnings per share
8,81
8,26
20,57
10,26
Interest and investment income
-
-
34,70 m
-
Interest expense
-495,50 m
-488,20 m
-456,00 m
-466,50 m
Net interest expenses
-495,50 m
-488,20 m
-421,30 m
-466,50 m
Depreciation and amortization charges
690,80 m
703,40 m
695,70 m
720,70 m
EBITDA
2,89 mjd
2,87 mjd
2,70 mjd
2,94 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme